Lower Urinary Tract Conditions: From the Editor
New Guidelines Cite Benefits of Cranberry Proanthocyanidins for UTI Prophylaxis, Further Validating Ellura® - The Innovator Behind Medical-Grade Supplement
Is Urine Production Rate at Night Uniform or Phasic in Patients Treated for Clinically Significant Nocturia?
A recent study from the European Urology Focus journal, “Differential Nocturnal Diuresis Rates Among Patients With and Without Nocturnal Polyuria Syndrome” the Veterans Affairs Health System analyzed frequency-volume charts of adult males with two or more nocturnal voids. After excluding patients with diuretic use, obstructive sleep apnea, chronic kidney disease, diabetes insipidus or edema, 130 subjects were included.
From the Desk of the Editor: "Advancing Medical Treatment for LUTS while Improving Patients Quality of Life"
From the Desk of the Editor - "The Impact our Therapies Have on Sleep"
Thanks to Gonzalez et al. we now have data that suggest we need to look at this impact. Recently published in cancer the study compares objective and subjective sleep disturbance in patients with prostate cancer receiving androgen deprivation therapy (ADT) compared with patients with prostate cancer previously treated with surgery only as well as men without a cancer history.
From the Desk of the Editor
I think of Nocturia as the “forgotten lower urinary tract condition”. Our understanding of sleep has recently come a long way, we are only now starting to understand the homeostatic effects of sleep. We now realize the impact of sleep quality on many domains of health and well-being. It is therefore more important than ever to address conditions that are have a negative impact on sleep and sleep quality. We need to realize that Nocturia is no longer just a symptom, but rather a condition with profound impact, regardless of age.